SGLT2is as Foundational Therapy in Adults with CKD There was a clear consensus that SGLT2is should be positioned as foundational therapy in adults with CKD and T2D, independent of BMI and in particular in the presence of HF, given their consistent kidney protective benefits and well-established mechanisms of action [20,21,22]
Selenoprotein One of a small number of proteins in mammalian cells that incorporate the unusual selenium-containing amino acid selenocysteine
While a nasal spray variation of Bremelanotide exists and was tested in clinical trials, intranasal administration is discouraged because of its higher incidence of adverse effects in some trials
For example, if you started semaglutide in 2024 with a BMI of 37 and your BMI has since dropped to 32, you still qualify
Pyroglutamic acid: throwing light on a lightly studied metabolite
This has been a God send, not just for my body but also my wallet